Literature DB >> 15244040

Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ARDS.

Shigeatsu Endo1, Nobuhiro Sato, Hajime Nakae, Yasuhiko Yamada, Hideyuki Makabe, Hajimu Abe, Satoko Imai, Go Wakabayashi, Katsuya Inada, Shigehiro Sato.   

Abstract

The levels of surfactant protein-A (SP-A) and surfactant protein-D (SP-D) in the serum of patients with septic acute respiratory distress syndrome (ARDS) were determined. Patients with sepsis without ARDS were examined as controls. The mean serum SP-A level in the former group was 37.6 +/- 16.2 ng/ml and in the latter group was 31.8 +/- 9.6 ng/ml. The difference between the two groups was not statistically significant. The maximum serum SP-D level was 83.0 +/- 33.9 ng/ml in the control group of patients without ARDS, and 476.3 +/- 391.2 ng/ml in the patients with ARDS. The level in the latter population was significantly higher than that in the former population. No significant correlation was observed between the SP-A and SP-D levels. These results suggest that the serum SP-D levels may serve as a good diagnostic indicator of ARDS in patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15244040

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  12 in total

Review 1.  Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise.

Authors:  M Isabel García-Laorden; José A Lorente; Carlos Flores; Arthur S Slutsky; Jesús Villar
Journal:  Ann Transl Med       Date:  2017-07

2.  Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.

Authors:  Jonathan A Kropski; Richard D Fremont; Carolyn S Calfee; Lorraine B Ware
Journal:  Chest       Date:  2009-02-02       Impact factor: 9.410

Review 3.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

Review 4.  Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury.

Authors:  Patricia Silveyra; Joanna Floros
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

5.  Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.

Authors:  Miao-Hsi Hsieh; Nazar Beirag; Valarmathy Murugaiah; Yu-Chi Chou; Wen-Shuo Kuo; Hui-Fang Kao; Taruna Madan; Uday Kishore; Jiu-Yao Wang
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

6.  Diagnostic value of surfactant protein-a in severe acute pancreatitis-induced acute respiratory distress syndrome.

Authors:  Bin Zhu; Feng Zheng; Ning Liu; Ming-Hui Zhu; Jun Xie; Ji-Ru Ye; Jun Zhang; Dan-Qian Jiang; Chun Yang; Yong Jiang
Journal:  Med Sci Monit       Date:  2014-09-26

7.  Surfactant protein-D (SP-D) gene polymorphisms and serum level as predictors of susceptibility and prognosis of acute kidney injury in the Chinese population.

Authors:  Jiao Liu; Guang Li; Lianghai Li; Zhiyong Liu; Qingshan Zhou; Guirong Wang; Dechang Chen
Journal:  BMC Nephrol       Date:  2017-02-17       Impact factor: 2.388

8.  An Unsettled Promise: The Newborn Piglet Model of Neonatal Acute Respiratory Distress Syndrome (NARDS). Physiologic Data and Systematic Review.

Authors:  Dietmar Spengler; Nele Rintz; Martin F Krause
Journal:  Front Physiol       Date:  2019-10-30       Impact factor: 4.566

9.  Surviving sepsis campaign: research priorities for sepsis and septic shock.

Authors:  Craig M Coopersmith; Daniel De Backer; Clifford S Deutschman; Ricard Ferrer; Ishaq Lat; Flavia R Machado; Greg S Martin; Ignacio Martin-Loeches; Mark E Nunnally; Massimo Antonelli; Laura E Evans; Judith Hellman; Sameer Jog; Jozef Kesecioglu; Mitchell M Levy; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2018-07-03       Impact factor: 17.440

10.  Elevated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARS patients.

Authors:  Y P Wu; Z H Liu; R Wei; S D Pan; N Y Mao; B Chen; J J Han; F S Zhang; U Holmskov; Z L Xia; P G de Groot; K B M Reid; W B Xu; G L Sorensen
Journal:  Scand J Immunol       Date:  2009-06       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.